Medlab Asia & Asia Health 2024 was held in Bangkok, Thailand from July 10th to 12th. For the third consecutive year, Hangzhou Laihe Biotech continued to participate in this most important professional exhibition for laboratory and diagnostic products radiating in Southeast Asia.

From fall/winter 2023 to spring 2024, the respiratory diseases infection has broken out again globally. In addition to the growing demand for COVID-19 tests, the demand for testing of Mycoplasma pneumoniae and Bordetella Pertussis and other respiratory diseases is also growing. Laihe Biotech responded quickly and developed Respiratory Multiple Rapid Test products to meet the market demand. A series of Respiratory Multiple Rapid Test products have been approved in Southeast Asia.

This year, the outbreak of dengue fever in South America and tropical regions of Asia has also brought a wave of continuous demand for dengue test products, LYHER Dengue test products have been approved in Thailand and will soon be licensed in Malaysia, Vietnam and Indonesia.

In 2024, Laihe Biotech launched a series of veterinary testing products, which gained a lot of attention. Laihe will continue to provide high-quality animal health testing products for future market needs.

This is the first year for Laihe Biotech to focus on the Asia-Pacific market. With the successful end of Medlab in Thailand, Laihe Biotech will continue  participate in the Medica exhibitions in Singapore in September, Vietnam in September and Indonesia in October. . We look forward to meeting with you to discuss more opportunities for cooperation.